IS4755A - Inndælanlegar kínólón samsetningar - Google Patents

Inndælanlegar kínólón samsetningar

Info

Publication number
IS4755A
IS4755A IS4755A IS4755A IS4755A IS 4755 A IS4755 A IS 4755A IS 4755 A IS4755 A IS 4755A IS 4755 A IS4755 A IS 4755A IS 4755 A IS4755 A IS 4755A
Authority
IS
Iceland
Prior art keywords
injectable
quinolone
formulations
quinolone formulations
injectable quinolone
Prior art date
Application number
IS4755A
Other languages
English (en)
Other versions
IS2010B (is
Inventor
Alan Boettner Wayne
Connor Canning Peter
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21735307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4755(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS4755A publication Critical patent/IS4755A/is
Publication of IS2010B publication Critical patent/IS2010B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4755A 1995-12-21 1998-05-25 Inndælanlegar kínólón samsetningar IS2010B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US905295P 1995-12-21 1995-12-21
PCT/IB1996/001217 WO1997023217A1 (en) 1995-12-21 1996-11-13 Injectable quinolone formulations

Publications (2)

Publication Number Publication Date
IS4755A true IS4755A (is) 1998-05-25
IS2010B IS2010B (is) 2005-05-13

Family

ID=21735307

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4755A IS2010B (is) 1995-12-21 1998-05-25 Inndælanlegar kínólón samsetningar

Country Status (42)

Country Link
US (1) US5811130A (is)
EP (1) EP0868183B1 (is)
JP (1) JP3416145B2 (is)
KR (1) KR100402570B1 (is)
CN (1) CN1104899C (is)
AP (1) AP706A (is)
AR (1) AR005147A1 (is)
AT (1) ATE212551T1 (is)
AU (1) AU709474B2 (is)
BG (1) BG63933B1 (is)
BR (1) BR9612230A (is)
CA (1) CA2239352C (is)
CO (1) CO4480098A1 (is)
CZ (1) CZ293747B6 (is)
DE (1) DE69618987T2 (is)
DK (1) DK0868183T3 (is)
DZ (1) DZ2146A1 (is)
EG (1) EG24071A (is)
ES (1) ES2167609T3 (is)
GT (1) GT199600098A (is)
HR (1) HRP960607B1 (is)
HU (1) HU227918B1 (is)
IL (1) IL124454A (is)
IS (1) IS2010B (is)
MA (1) MA24035A1 (is)
MX (1) MX9805026A (is)
MY (1) MY117109A (is)
NO (1) NO315734B1 (is)
NZ (2) NZ501160A (is)
OA (1) OA10697A (is)
PE (1) PE25798A1 (is)
PL (1) PL186795B1 (is)
PT (1) PT868183E (is)
RS (1) RS49523B (is)
RU (1) RU2141827C1 (is)
SI (1) SI0868183T1 (is)
SK (1) SK284412B6 (is)
TN (1) TNSN96163A1 (is)
TW (1) TW449475B (is)
UA (1) UA56151C2 (is)
WO (1) WO1997023217A1 (is)
ZA (1) ZA9610780B (is)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21415A (id) * 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
AU2001228454A1 (en) * 2000-01-13 2001-07-24 Merck Patent G.M.B.H Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
WO2002053136A1 (fr) * 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Preparations a liberation soutenue
MXPA05000011A (es) * 2002-06-26 2005-04-08 Pharmacia Corp Formulacion parenteral liquida estable de parecoxib.
WO2006004028A1 (ja) * 2004-07-02 2006-01-12 Daiichi Pharmaceutical Co., Ltd. キノロン含有医薬組成物
DK2594272T3 (en) * 2005-05-18 2018-09-03 Horizon Orphan Llc Aerosolized fluoroquinolones and their applications
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
FR2896416B1 (fr) 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
MX2008010222A (es) * 2006-02-10 2008-10-17 Pari Pharma Gmbh Antibioticos nebulizados para terapia de inhalacion.
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
MX2007009796A (es) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
KR20160150110A (ko) 2008-10-07 2016-12-28 랩터 파마슈티컬스 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
LT2473170T (lt) 2009-09-04 2019-10-10 Horizon Orphan Llc Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
CA2987879A1 (en) 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Aqueous drug
JP6675396B2 (ja) 2015-06-02 2020-04-01 杏林製薬株式会社 水性液剤
US10406149B2 (en) 2015-06-02 2019-09-10 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid formulation
RU2019128568A (ru) * 2017-02-13 2021-03-15 Байер Энимэл Хельс ГмбХ Жидкая композиция, содержащая прадофлоксацин
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US523505A (en) * 1894-07-24 Island
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
JPS63188626A (ja) * 1987-01-30 1988-08-04 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸の可溶化方法
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
JP3153549B2 (ja) * 1989-12-29 2001-04-09 アボツト・ラボラトリーズ キノロンカルボン酸―金属イオン―酸錯体
US5084276A (en) * 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
ATE108649T1 (de) * 1990-02-14 1994-08-15 Takeda Chemical Industries Ltd Brausemischung, deren herstellung sowie verwendung.
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
JPH0782141A (ja) * 1993-09-17 1995-03-28 Tanabe Seiyaku Co Ltd 動物用注射剤

Also Published As

Publication number Publication date
NZ320545A (en) 2000-03-27
AP706A (en) 1998-12-04
AU709474B2 (en) 1999-08-26
HUP9903726A3 (en) 2001-01-29
ATE212551T1 (de) 2002-02-15
CZ193098A3 (cs) 1999-05-12
EG24071A (en) 2008-05-11
PL186795B1 (pl) 2004-02-27
NO982842D0 (no) 1998-06-19
BR9612230A (pt) 1999-07-13
TNSN96163A1 (fr) 2005-03-15
GT199600098A (es) 1998-06-12
NZ501160A (en) 2001-10-26
RS49523B (sr) 2006-10-27
TW449475B (en) 2001-08-11
SK80798A3 (en) 1999-09-10
OA10697A (en) 2001-05-04
PE25798A1 (es) 1998-05-21
IL124454A (en) 2003-10-31
CZ293747B6 (cs) 2004-07-14
CN1104899C (zh) 2003-04-09
CA2239352C (en) 2002-06-04
CN1205636A (zh) 1999-01-20
CO4480098A1 (es) 1997-07-09
ES2167609T3 (es) 2002-05-16
IL124454A0 (en) 1998-12-06
JP3416145B2 (ja) 2003-06-16
WO1997023217A1 (en) 1997-07-03
SI0868183T1 (en) 2002-04-30
DE69618987D1 (de) 2002-03-14
DZ2146A1 (fr) 2002-10-23
EP0868183B1 (en) 2002-01-30
HRP960607A2 (en) 1998-06-30
IS2010B (is) 2005-05-13
AR005147A1 (es) 1999-04-14
YU69096A (sh) 1999-06-15
MX9805026A (es) 1998-09-30
BG102542A (en) 1999-06-30
JPH11501331A (ja) 1999-02-02
PT868183E (pt) 2002-06-28
SK284412B6 (sk) 2005-03-04
EP0868183A1 (en) 1998-10-07
ZA9610780B (en) 1998-06-22
PL328001A1 (en) 1999-01-04
KR19990076617A (ko) 1999-10-15
NO982842L (no) 1998-06-19
DK0868183T3 (da) 2002-03-25
US5811130A (en) 1998-09-22
HRP960607B1 (en) 2002-06-30
HUP9903726A2 (hu) 2000-04-28
HU227918B1 (en) 2012-06-28
BG63933B1 (bg) 2003-07-31
KR100402570B1 (ko) 2003-12-18
RU2141827C1 (ru) 1999-11-27
NO315734B1 (no) 2003-10-20
DE69618987T2 (de) 2002-11-21
UA56151C2 (uk) 2003-05-15
CA2239352A1 (en) 1997-07-03
AP9600898A0 (en) 1997-01-31
MA24035A1 (fr) 1997-07-01
MY117109A (en) 2004-05-31
AU7328996A (en) 1997-07-17

Similar Documents

Publication Publication Date Title
ATE212551T1 (de) Injizierbare quinolonformulierungen
NO2011015I1 (no) Pallperidon palmitatester
FI974241A0 (fi) BPM-15 -koostumukset
ID18352A (id) Komposisi-komposisi farmasi
FI991302A7 (fi) Parannetut farmaseuttiset koostumukset
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
ID17860A (id) Komposisi vaksin
ATE293672T1 (de) Farbschonende zusammensetzungen
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
DE69617029D1 (de) Organoton-zusammensetzungen
NO981568D0 (no) Randtennings-tennsatssammensetninger
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID16781A (id) Formulasi-formulasi farmasi
PT941100E (pt) Composicoes farmaceuticas
DE69603228D1 (de) Aluminoxanate-Zusammensetzungen
DE59708449D1 (de) Substituierte p-trifluormethylphenyluracile
DE59707428D1 (de) Substituierte 1-methyl-3-benzyluracile
ATE206150T1 (de) Farbstoffstabilisierte zusammensetzungen
DE59711889D1 (de) Substituierte pyrazol-3-ylbenzazole
FI961364L (fi) Lääkeainekoostumus
ITMI962628A0 (it) Composizione farmaceutica
DE59708674D1 (de) Substituierte 3-phenylpyrazole
DE59712222D1 (de) Substituierte phenyluracile
ID21960A (id) Komposisi-komposisi hidrofluorokarbon
SE9601854D0 (sv) Farmaceutisk komposition